XML 43 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

Stockholders’ Equity (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2024 | Dec. 31, 2023
Equity [Abstract] |  |
Schedule of Warrants Activity | A summary of activity regarding all warrants issued for the six months ended June 30, 2024 were as follows: Schedule of Warrants Activity
|  | Number of |  |  | Weighted Average |  |  | Average |
|  | Warrants Shares |  |  | Exercise Price |  |  | Life (years) |
Outstanding, December 31, 2023 |  |  | 184,000 |  |  | $ | 23.20 |  |  |  | 2.77 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Outstanding, June 30, 2024 |  |  | 184,000 |  |  | $ | 23.20 |  |  |  | 2.29 |
| A summary of activity regarding all warrants issued for the year ended December 31, 2023 and 2022 were as follows: Schedule of Warrants Activity
|  | Number of |  |  | Weighted Average |  |  | Weighted Average |
|  | Warrants |  |  | Exercise Price |  |  | Life (years) |
|  | (as restated) |  |  | (as restated) |  |  | (as restated) |
Outstanding, December 31, 2021 |  |  | 62,500 |  |  | $ | 8.00 |  |  |  | 4.99 |
Granted(1) |  |  | 270,910 |  |  |  | 14.57 |  |  |  | 4.68 |
Exercised(2) |  |  | (285,579 | ) |  |  | 9.58 |  |  |  | — |
Outstanding, December 31, 2022 |  |  | 47,831 |  |  |  | 35.77 |  |  |  | 2.78 |
Granted - Boustead |  |  | 8,909 |  |  |  | 18.80 |  |  |  | 5.00 |
Granted - Ayrton |  |  | 127,260 |  |  |  | 18.80 |  |  |  | 4.00 |
Outstanding, December 31, 2023 |  |  | 184,000 |  |  |  | 23.21 |  |  |  | 2.77 |
| (1) | Granted warrants include those granted on the issuance of the August 2022 Promissory Notes (3,750 warrants); Notes Payable – Related Parties (2,500 warrants); upon conversion of the Series A Preferred Shares (42,114 warrants); automatic conversion of the 2022 Convertible Notes (18,447 warrants); issued during the IPO, including overallotment option (176,222 warrants) and issued to Boustead Securities LLC (27,877 warrants).
| (2) | Exercised warrants include the exercise of the warrants issued with the December 2021 Notes (62,500 warrants); the exercise of the warrants issued with the August 2022 Notes (3,750 warrants); the exercise of the warrants issued upon conversion of the Convertible Notes (18,447 warrants); and the exercise of the warrants issued during the IPO, including overallotment option (176,222 warrants), and warrants exercised on a cashless basis (24,660 warrants).
Schedule of Restricted Stock Units (RSUs) | A summary of activity regarding the Restricted Stock Units issued follows: Schedule of Restricted Stock Units (RSUs)
|  | Number of RSUs |  |  | Weighted Average Fair Value Per RSU |
Outstanding, December 31, 2023 |  |  | 24,731 |  |  | $ | 11.76 |
Granted |  |  | 53,455 |  |  |  | 2.65 |
Vested |  |  | (19,347 | ) |  |  | 7.58 |
Outstanding, June 30, 2024 |  |  | 58,839 |  |  | $ | 4.87 |
| A summary of activity regarding the Restricted Stock Units issued follows: Schedule of Restricted Stock Units (RSUs)
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
Outstanding, December 31, 2021 (as restated) |  |  | 2,017 |  |  | $ | 185.60 |
Granted |  |  | 4,449 |  |  |  | 22.48 |
Vested (as restated) |  |  | (3,500 | ) |  |  | 116.48 |
Outstanding, December 31, 2022 (as restated) |  |  | 2,966 |  |  | $ | 22.48 |
Granted |  |  | 32,415 |  |  |  | 10.88 |
Vested (as restated) |  |  | (10,650 | ) |  |  | 12.00 |
Outstanding, December 31, 2023 |  |  | 24,731 |  |  | $ | 11.76 |
Schedule of Restricted Stock Units |  | Schedule of Restricted Stock Units
|  | 2023 |  | 2022
|  | Year ended December 31,
|  | 2023 |  | 2022
|  |  |  | (as restated)
Recognized in general and administrative expense |  | $ | 115,000 |  |  | $ | 105,582 |
Recognized in research and development expense |  |  | 66,960 |  |  |  | 131,965 |
Total |  | $ | 181,960 |  |  | $ | 237,547 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration